Skip to main content
. 2019 Oct 15;10(25):6207–6216. doi: 10.7150/jca.37335

Figure 1.

Figure 1

Representative immunohistochemical staining for p53, PCDH17 and Beclin-1 in urinary bladder cancer, which is expressed in the nuclear or cytoplasm (200 ×). Case 1: p53 mutation/ p53 wild-type (A, D); Case 2: PCDH17 mutation/ PCDH17 wild-type (B, E); Case 3: Beclin-1 mutation/ Beclin-1 wild-type (C, F).